2004peer-reviewed2,547 citations
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Stevo Julius, Sverre E. Kjeldsen, Michael A. Weber, Hans R. Brunner, Steffan Ekman, Lennart Hansson +4 more
The Lancet
Concepts
AmlodipineMedicineValsartanBlood pressureHazard ratioClinical endpointInternal medicineRegimen